CareDx: Pay

CareDx paid its 2 named executives $6.3M in total in FY2024 (Dec).

Pay of each named executive

Jessica MengChief Commercial Officer
FY2024 (Dec)Not disclosed
1 year

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 9 peers with pay on file was $9.1M. The CEO of CareDx was paid $7.2M, 21% below the median.

  1. 1Natera
  2. 2Twist Bioscience
  3. 3TransMedics Group
  4. 4AtriCure
  5. 5Adaptive Biotechnologies
  6. 6Veracyte
  7. 7CareDx
  8. 8Castle Biosciences
  9. 910x Genomics
  10. 10Myriad Genetics
  11. 11Alphatec Spine, Inc.Not disclosed
  12. 12Cerus CorporationNot disclosed
  13. 13Cytek Biosciences, Inc.Not disclosed
  14. 14Fulgent Genetics, Inc.Not disclosed
  15. 15Guardant HealthNot disclosed
  16. 16Maravai Lifesciences, Inc.Not disclosed
  17. 17NeogenomicsNot disclosed
  18. 18Pacific Biosciences of CaliforniaNot disclosed
  19. 19Quanterix CorporationNot disclosed
  20. 20Standard Bio Tools, Inc.Not disclosed
  21. 21iRhythm Technologies, Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.